{"transactions":[{"id":792226,"issuer":{"id":2063,"kind":"organization","name":"Tenon Medical, Inc.","symbol":"TNON"},"owners":[{"id":49701,"kind":"person","name":"Grawey Nathaniel A.","position":1,"cik":"0002081212","reported_name":"Grawey Nathaniel A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common stock","published_at":"2026-05-05T23:42:00.000Z","date":"2026-05-01","kind":"grant","planned":false,"acquired":true,"shares":68201,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By SiVantage, Inc."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"On May 1, 2026, Tenon Medical, Inc. (\"Registrant\") issued 276,228 shares of its common stock to SiVantage, Inc. (\"SiVantage\") pursuant to the Asset Purchase Agreement, dated August 1, 2025, by and between the Registrant and SiVantage, in connection with the achievement of a certain milestone set forth therein. The securities reported herein represent the reporting person's indirect pecuniary interest in the shares held by SiVantage based on the reporting person's 24.69% equity interest in SiVantage. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest."}],"balance_after":243584,"source":{"system":"sec-edgar","filing":"0001213900-26-052436","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2081212/000121390026052436/ownership.xml","form_type":"4"}},{"id":996241,"issuer":{"id":2063,"kind":"organization","name":"Tenon Medical, Inc.","symbol":"TNON"},"owners":[{"id":49701,"kind":"person","name":"Grawey Nathaniel A.","position":1,"cik":"0002081212","reported_name":"Grawey Nathaniel A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock Purchase Warrant","published_at":"2025-11-19T01:01:06.000Z","date":"2025-11-14","kind":"purchase","planned":false,"acquired":true,"shares":101167,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 10, 2025, the Issuer entered into a Securities Purchase Agreement for an at-the-market private investment in public equity transaction, in which the reporting person purchased 101,167 shares of common stock of the Issuer and warrants to purchase up to 101,167 shares of common stock of the Issuer. The purchase price for each share of common stock and accompanying warrant was $1.285. The offering closed on November 14, 2025."}],"balance_after":101167,"derivative":{"exercise_price":1.16,"exercise_date":"2025-11-14","expiration_date":"2028-11-14","underlying":"Common Stock","underlying_shares":101167},"source":{"system":"sec-edgar","filing":"0001213900-25-112295","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2081212/000121390025112295/ownership.xml","form_type":"4"}},{"id":996240,"issuer":{"id":2063,"kind":"organization","name":"Tenon Medical, Inc.","symbol":"TNON"},"owners":[{"id":49701,"kind":"person","name":"Grawey Nathaniel A.","position":1,"cik":"0002081212","reported_name":"Grawey Nathaniel A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common stock","published_at":"2025-11-19T01:01:06.000Z","date":"2025-11-14","kind":"purchase","planned":false,"acquired":true,"shares":101167,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 10, 2025, the Issuer entered into a Securities Purchase Agreement for an at-the-market private investment in public equity transaction, in which the reporting person purchased 101,167 shares of common stock of the Issuer and warrants to purchase up to 101,167 shares of common stock of the Issuer. The purchase price for each share of common stock and accompanying warrant was $1.285. The offering closed on November 14, 2025."}],"balance_after":239281,"source":{"system":"sec-edgar","filing":"0001213900-25-112295","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2081212/000121390025112295/ownership.xml","form_type":"4"}}]}